China SXT Pharmaceuticals (SXTC) Change in Account Payables (2018 - 2025)

China SXT Pharmaceuticals' Change in Account Payables history runs 8 years deep, the most recent figure standing at $530662.0 for Q3 2025.

• In Q3 2025, Change in Account Payables fell 68.08% year-over-year to $530662.0; the TTM figure through Sep 2025 stood at $530662.0 (down 68.08% YoY), while the FY2025 annual figure was $1.2 million, down 9.47% from the prior year.
• Change in Account Payables was $530662.0 for Q3 2025 at China SXT Pharmaceuticals, down from $1.2 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $1.7 million in Q3 2024 to a low of $530662.0 in Q3 2025.
• Historically, Change in Account Payables has averaged $1.3 million across 5 years, with a median of $1.4 million in 2021.
• The sharpest annual moves came in 2024 and 2025: Change in Account Payables rose 26.36% in 2024, then plunged 68.08% in 2025.
• A 5-year view of Change in Account Payables shows it stood at $1.5 million in 2021, then rose by 4.6% to $1.6 million in 2022, then dropped by 15.72% to $1.3 million in 2023, then gained by 26.36% to $1.7 million in 2024, then slumped by 68.08% to $530662.0 in 2025.
• The last three Change in Account Payables figures came in at $530662.0 (Q3 2025), $1.2 million (Q1 2025), and $1.7 million (Q3 2024), per Business Quant data.